← all signals · sectors · research

CytomX Therapeutics, Inc. CTMX

SIC 2834 — Pharmaceutical Preparations · CIK 1501989

This page lists every Interactive Market Data signal that fired on this company across fiscal years, with the calibrated net-of-cost forward-return prediction. Predictions use a triple → pair → singles fallback against our backtest panel (~32K (cik × fy) signal combos, net of execution costs at 5 bps half-spread + ADV-tiered borrow).

FY2025 short

1 signal fired · match: singles_avg

profit_to_loss

HorizonPredicted net PnL
20 days+0.79%
60 days-3.72%
252 days (1y)-17.43%

FY2024 long

2 signals fired · match: pair

accruals_quality_low, fcf_ni_divergence

HorizonPredicted net PnL
20 days+0.66%
60 days+4.42%
252 days (1y)+19.37%

FY2021 short

1 signal fired · match: singles_avg

fcf_turn_negative

HorizonPredicted net PnL
20 days+1.36%
60 days-1.61%
252 days (1y)-16.85%

FY2020 long

1 signal fired · match: singles_avg

fcf_turn_positive

HorizonPredicted net PnL
20 days+1.81%
60 days+4.48%
252 days (1y)+19.70%

FY2019 short

1 signal fired · match: singles_avg

capex_spike

HorizonPredicted net PnL
20 days+2.05%
60 days-0.78%
252 days (1y)-14.91%

FY2018 short

2 signals fired · match: pair

capex_spike, fcf_turn_negative

HorizonPredicted net PnL
20 days+2.92%
60 days+1.26%
252 days (1y)-2.11%

FY2017 long

1 signal fired · match: singles_avg

fcf_turn_positive

HorizonPredicted net PnL
20 days+1.81%
60 days+4.48%
252 days (1y)+19.70%

Methodology: /methodology · Live JSON: /api/company/1501989/financials